Publications - 'P'
Publications 1101 - 1125 de 2458
| Titre | DOI |
|---|---|
|
POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) WITH DELETION DEL(17P) AND/OR TRANSLOCATION T(4;14) X. Leleu; M. Macro; L. Karlin; C. Hulin; L. Garderet; M. Roussel; B. Arnulf; B. Pegourie; B. Kolb; A.M. Stoppa; S. Brechiniac; M. Michallet; G. Marit; C. Mathiot; A. Banos; L. Lacotte; M. Dib; J.G. Fuzibet; M.O. Petillon; P. Rodon; M. Wetterwald; B. Royer; L. Legros; L. Benboubker; O. Decaux; D. Caillot; M. Escoffre-Barbe; J.P. Fermand; P. Moreau; M. Attal; H. Avet-Loiseau; T. Facon 2014 |
|
|
POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) WITH DELETION DEL(17P) AND/OR TRANSLOCATION T(4;14) X. Leleu; M. Macro; L. Karlin; C. Hulin; L. Garderet; M. Roussel; B. Arnulf; B. Pegourie; B. Kolb; A.M. Stoppa; S. Brechiniac; M. Michallet; G. Marit; C. Mathiot; A. Banos; L. Lacotte; M. Dib; J.G. Fuzibet; M.O. Petillon; P. Rodon; M. Wetterwald; B. Royer; L. Legros; L. Benboubker; O. Decaux; D. Caillot; M. Escoffre-Barbe; J.P. Fermand; P. Moreau; M. Attal; H. Avet-Loiseau; T. Facon 2014 |
|
|
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma L. Garderet; F. Kuhnowski; B. Berge; M. Roussel; M. Escoffre-Barbe; I. Lafon; T. Facon; X. Leleu; L. Karlin; A. Perrot; P. Moreau; G. Marit; A.M. Stoppa; B. Royer; C. Chaleteix; M. Tiab; C. Araujo; P. Lenain; M. Macro; E. Voog; L. Benboubker; O. Allangba; E. Jourdan; F. Orsini-Piocelle; S. Brechignac; J.R. Eveillard; K. Belhadj; M. Wetterwald; B. Pegourie; A. Jaccard; J.C. Eisenmann; S. Glaisner; M. Mohty; C. Hulin; H. Avet-Loiseau; C. Mathiot; M. Attal 2018 |
10.1182/blood-2018-07-863829 |
|
PONATINIB EVALUATION AND SAFETY IN REAL LIFE CHRONIC PHASE (CP) CML PATIENTS FAILING >= 2 TYROSINE KINASE INHIBITORS (TKI): UPDATE OF THE PEARL OBSERVATIONAL STUDY F.E. Nicolini; M. Heiblig; D. Caillot; A. Charbonnier; P. Rousselot; V. Coiteux; M. Escoffre-Barbe; V. Dubruille; F. Huguet; F. Guilhot; E. Hermet; A. Guerci-Bresler; S. Ame; P. Mouchel; L. Roy; S. Morisset; G. Etienne; D. Rea 2016 |
|
|
Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study M. Heiblig; D. Rea; M.L. Chretien; A. Charbonnier; P. Rousselot; V. Coiteux; M. Escoffre-Barbe; V. Dubruille; F. Huguet; E. Cayssials; E. Hermet; A. Guerci-Bresler; S. Ame; L. Sackmann-Sala; L. Roy; M. Sobh; S. Morisset; G. Etienne; F.E. Nicolini 2018 |
10.1016/j.exphem.2018.08.006 |
|
Ponatinib for Chronic Phase (CP) CML Failing Two or More Tyrosine Kinase Inhibitors (TKI) or Harboring a T315I Mutation in the Real Life: Pearl Observational Study F.E. Nicolini; M. Heiblig; S. Morisset; D. Caillot; V. Coiteux; A. Charbonnier; F. Huguet; V. Dubruille; G. Etienne; P. Lenain; F. Guilhot; L. Legros; P. Rousselot; S. Ame; R. DeFrance; J. Ruby; F.X. Mahon; D. Rea 2015 |
|
|
Pontryagin-Type Conditions for Optimal Muscular Force Response to Functional Electrical Stimulations T. Bakir; B. Bonnard; L. Bourdin; J. Rouot 2020 |
10.1007/s10957-019-01599-4 |
|
Pontryagin-Type Conditions for Optimal Muscular Force Response to Functional Electrical Stimulations T. Bakir; B. Bonnard; L. Bourdin; J. Rouot 2020 |
10.1007/s10957-019-01599-4, Early Access Date = {NOV 2019 |
|
Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy X. Pivot; F. Marme; R. Koenigsberg; M. Guo; E. Berrak; A. Wolfer 2016 |
10.1093/annonc/mdw203 |
|
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma S. Kim; A. Meurisse; L. Spehner; M. Stouvenot; E. Francois; B. Buecher; T. Andre; E. Samalin; M. Jary; T. Nguyen; F.El Hajbi; N. Hamed; S. Pernot; M.C. Kaminsky; O. Bouche; J. Desrame; M. Zoubir; F. Ghiringhelli; A. Parzy; C. de la Fouchardiere; F. Boulbair; Z. Lakkis; E. Klajer; M. Jacquin; J. Taieb; V. Vendrely; D. Vernerey; C. Borg 2020 |
10.1177/1758835920975356 |
|
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC) E.Rivin del Campo; O. Matzinger; K. Haustermans; D. Peiffert; R. Glynne-Jones; K.A. Winter; A.A. Konski; J.A. Ajani; J.F. Bosset; J.M. Hannoun-Levi; M. Puyraveau; B. Chakravarthy; H. Meadows; J. Northover; L. Collette; M. Christiaens; P. Maingon 2019 |
10.1016/j.ejca.2019.08.022 |
|
Poor glycaemic control is associated with decreased survival in patients with diabetes following lung transplantation K. Hackman; G. Snell; L. Bach 2016 |
|
|
Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy - a Study By the Lysa Group Y.L.E. Bris; O. Theisen; A. Moreau; F. Magrangeas; D. Canioni; B. Burroni; C. Thieblemont; L. Oberic; K. Bouabdallah; E. Gyan; D. Chiron; C. Pellat-Deceunynck; B. Tessoulin; C. Godon; M.H. Delfau; M. Callanan; S. Minvielle; M.C. Bene; O. Hermine; S.L.E. Gouill 2018 |
10.1182/blood-2018-99-113303 |
|
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia A. Bidet; S. Dulucq; T. Smol; A. Marceau-Renaut; S. Morisset; V. Coiteux; M.P. Noel-Walter; F.E. Nicolini; I. Tigaud; I. Luquet; S. Struski; B. Gaillard; D. Penther; S. Tondeur; N. Nadal; E. Hermet; L. Veronese; D. Rea; C. Gervais; O. Theisen; C. Terre; P. Cony-Makhoul; C. Lefebvre; J.B. Gaillard; I. Radford; A.L. Vervaeke; C. Barin; E. Chapiro; F. Nguyen-Khac; G. Etienne; C. Preudhomme; F.Xavier Mahon; C. Roche-Lestienne; G.Francophon Cytogenetique; F.Intergroup Myeloid 2019 |
10.3324/haematol.2018.208801 |
|
Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study S. Gendreau; B. Thoreau; F. Maurier; T. Goulenok; L. Frumholtz; A. Mekinian; S. Oro; C. Bernigaud; A. Audemard; M. Samson; A. Gaillet; R. Sonneville; J.B. Arlet; A. Mirouse; J.E. Kahn; A. Hummel; T. Pires; W. Jourde; E. Hachulla; P.L. Carron; C.A. Durel; F. Sarrot-Reynauld; N. Tieulie; E. Diot; C. Agard; G. Armengol; A. Berezne; C. Deligny; F. Cohen; S. Faguer; G. Le Guenno; M. Hamidou; L. Guillevin; B. Terrier 2019 |
|
|
Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study S. Gendreau; B. Thoreau; F. Maurier; T. Goulenok; L. Frumholtz; A. Mekinian; S. Oro; C. Bernigaud; A. Audemard; M. Samson; A. Gaillet; R. Sonneville; J.B. Arlet; A. Mirouse; J.E. Kahn; A. Hummel; T. Pires; W. Jourde; E. Hachulla; P.L. Carron; C.A. Durel; F. Sarrot-Reynauld; N. Tieulie; E. Diot; C. Agard; G. Armengol; A. Berezne; C. Deligny; F. Cohen; S. Faguer; G. Le Guenno; M. Hamidou; L. Guillevin; B. Terrier 2019 |
|
|
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort T. Walter; D. Tougeron; E. Baudin; K. Le Malicot; T. Lecomte; D. Malka; O. Hentic; S. Manfredi; I. Bonnet; R. Guimbaud; R. Coriat; C. Lepere; C. Desauw; A. Thirot-Bidault; L. Dahan; G. Roquin; T. Aparicio; J.L. Legoux; C. Lombard-Bohas; J.Y. Scoazec; C. Lepage; G. Cadiot; C.E.P.D. Investigators 2017 |
10.1016/j.ejca.2017.04.009 |
|
Pop-up structure in massive carbonate-hosted fold-and-thrust belt: Insight from field mapping and 2D kinematic model in the central Apennines S. Fabbi; L. Smeraglia 2019 |
10.1016/j.jsg.2019.06.011 |
|
Poplar biomass production at phytomanagement sites is significantly enhanced by mycorrhizal inoculation L. Ciadamidaro; O. Girardclos; V. Bert; C. Zappelini; L. Yung; J. Foulon; A. Papin; S. Roy; D. Blaudez; M. Chalot 2017 |
10.1016/j.envexpbot.2017.04.004 |
|
Poplar rotation coppice at a trace element-contaminated phytomanagement site: A 10-year study revealing biomass production, element export and impact on extractable elements M. Chalot; O. Girardclos; L. Ciadamidaro; C. Zappelini; L. Yung; A. Durand; S. Pfendler; I. Lamy; V. Driget; D. Blaudez 2020 |
10.1016/j.scitotenv.2019.134260 |
|
Popular Music and the Anthropocene: Call For Articles F. Ribac; P. Harkins 2018 |
10.1017/S0261143018000235 |
|
Popularity of patterns over d-equivalence classes of words and permutations J.L. Baril; V. Vajnovszki 2020 |
10.1016/j.tcs.2020.02.005 |
|
Population and evolutionary genetics of the PAH locus to uncover overdominance and adaptive mechanisms in phenylketonuria: Results from a multiethnic study A. Oussalah; E. Jeannesson-Thivisol; C. Chery; P. Perrin; P. Rouyer; T. Josse; A. Cano; M. Barth; A. Fouilhoux; K. Mention; F. Labarthe; J.B. Arnoux; F. Maillot; C. Lenaerts; C. Dumesnil; K. Wagner; D. Terral; P. Broue; L. De Parscau; C. Gay; A. Kuster; A. Bedu; G. Besson; D. Lamireau; S. Odent; A. Masurel; R.M. Rodriguez-Gueant; F. Feillet; J.L. Gueant; F. Namour 2020 |
10.1016/j.ebiom.2019.102623 |
|
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients N. Lunar; M.C. Etienne-Grimaldi; P. Macaire; F. Thomas; F. Dalenc; J.M. Ferrero; X. Pivot; G. Milano; B. Royer; A. Schmitt 2021 |
10.1007/s00280-020-04208-8, Early Access Date = {JAN 2021 |
|
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients N. Lunar; M.C. Etienne-Grimaldi; P. Macaire; F. Thomas; F. Dalenc; J.M. Ferrero; X. Pivot; G. Milano; B. Royer; A. Schmitt 2021 |
10.1007/s00280-020-04208-8 |